- Home
- PSNYW vs QURE Comparison
PSNYW vs QURE Comparison
Compare PSNYW & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNYW
- QURE
- Stock Information
- Founded
- PSNYW N/A
- QURE 1998
- Country
- PSNYW Sweden
- QURE Netherlands
- Employees
- PSNYW 2515
- QURE N/A
- Industry
- PSNYW Auto Manufacturing
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- PSNYW Consumer Discretionary
- QURE Health Care
- Exchange
- PSNYW Nasdaq
- QURE Nasdaq
- Market Cap
- PSNYW 493.0M
- QURE 432.6M
- IPO Year
- PSNYW N/A
- QURE 2007
- Fundamental
- Price
- PSNYW $0.23
- QURE $7.33
- Analyst Decision
- PSNYW
- QURE Buy
- Analyst Count
- PSNYW 0
- QURE 6
- Target Price
- PSNYW N/A
- QURE $17.00
- AVG Volume (30 Days)
- PSNYW N/A
- QURE 699.6K
- Earning Date
- PSNYW N/A
- QURE 11-05-2024
- Dividend Yield
- PSNYW N/A
- QURE N/A
- EPS Growth
- PSNYW N/A
- QURE N/A
- EPS
- PSNYW N/A
- QURE N/A
- Revenue
- PSNYW N/A
- QURE $28,587,000.00
- Revenue This Year
- PSNYW N/A
- QURE $178.43
- Revenue Next Year
- PSNYW N/A
- QURE $49.15
- P/E Ratio
- PSNYW N/A
- QURE N/A
- Revenue Growth
- PSNYW N/A
- QURE N/A
- 52 Week Low
- PSNYW N/A
- QURE $3.73
- 52 Week High
- PSNYW N/A
- QURE $11.35
- Technical
- Relative Strength Index (RSI)
- PSNYW 49.60
- QURE 61.28
- Support Level
- PSNYW $0.20
- QURE $5.35
- Resistance Level
- PSNYW $0.25
- QURE $7.28
- Average True Range (ATR)
- PSNYW 0.02
- QURE 0.50
- MACD
- PSNYW 0.00
- QURE 0.04
- Stochastic Oscillator
- PSNYW 47.84
- QURE 85.75
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.